US Stock MarketDetailed Quotes
ICCM Icecure Medical
- 0.712
- +0.114+19.02%
Close Nov 22 16:00 ET
- 0.700
- -0.012-1.71%
Post 20:01 ET
39.53MMarket Cap-2455P/E (TTM)
0.756High0.591Low1.69MVolume0.598Open0.598Pre Close1.13MTurnover6.01%Turnover RatioLossP/E (Static)55.50MShares1.57052wk High3.73P/B19.97MFloat Cap0.48052wk Low--Dividend TTM28.04MShs Float16.000Historical High--Div YieldTTM27.64%Amplitude0.480Historical Low0.667Avg Price1Lot Size
Icecure Medical Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.90%1.01M | 4.65%743K | 4.67%3.23M | 33.65%1.26M | -48.42%327K | 22.48%937K | -4.95%710K | -25.45%3.09M | -32.15%939K | -6.90%634K |
| Operating revenue | 7.90%1.01M | 4.65%743K | 4.67%3.23M | 33.65%1.26M | -48.42%327K | 22.48%937K | -4.95%710K | -25.45%3.09M | -32.15%939K | -6.90%634K |
| Cost of revenue | -4.37%481K | 21.54%474K | 17.62%1.93M | 43.51%686K | -25.21%350K | 32.02%503K | 24.60%390K | -15.59%1.64M | -35.49%478K | 45.34%468K |
| Gross profit | 22.12%530K | -15.94%269K | -10.03%1.3M | 23.43%569K | -113.86%-23K | 13.02%434K | -26.27%320K | -34.17%1.45M | -28.30%461K | -53.76%166K |
| Operating expense | -16.77%3.76M | -8.37%3.92M | -7.19%16.88M | -9.31%3.98M | -3.91%4.1M | -3.22%4.52M | -11.98%4.28M | 52.56%18.18M | 16.49%4.39M | 32.97%4.27M |
| Selling and administrative expenses | -10.80%2.17M | -9.14%1.97M | -5.05%8.6M | -2.55%2.1M | -6.40%1.9M | 1.08%2.44M | -12.13%2.17M | 49.97%9.06M | -0.65%2.16M | 22.07%2.03M |
| -Selling and marketing expense | 6.79%1.26M | -3.44%1.04M | 16.55%1.21M | -68.72%-2.02M | 39.15%981K | 49.87%1.18M | 43.91%1.08M | 56.01%1.04M | -117.60%-1.2M | 19.09%705K |
| -General and administrative expense | -27.27%915K | -14.76%930K | -7.85%7.39M | 22.92%4.12M | -30.64%919K | -22.54%1.26M | -36.50%1.09M | 49.22%8.02M | 23.30%3.36M | 23.72%1.33M |
| Research and development costs | -23.76%1.59M | -7.58%1.95M | -9.32%8.27M | -15.82%1.88M | -1.65%2.2M | -7.80%2.08M | -11.82%2.11M | 55.23%9.12M | 39.73%2.24M | 44.70%2.24M |
| Operating profit | 20.90%-3.23M | 7.76%-3.65M | 6.95%-15.58M | 13.15%-3.42M | -0.54%-4.12M | 4.67%-4.08M | 10.58%-3.96M | -72.14%-16.74M | -25.70%-3.93M | -43.89%-4.1M |
| Net non-operating interest income expense | -23.44%147K | -78.31%41K | 486.61%924K | 2,200.00%420K | 186.05%123K | 180.00%192K | 959.09%189K | -39.77%-239K | 37.50%-20K | 213.16%43K |
| Total other finance cost | ---- | 78.31%-41K | -486.61%-924K | -2,200.00%-420K | ---- | ---- | -959.09%-189K | 39.77%239K | --20K | ---43K |
| Other net income (expense) | ||||||||||
| Income before tax | 20.78%-3.08M | 4.22%-3.61M | 13.70%-14.65M | 24.22%-3M | 1.43%-4M | 13.98%-3.89M | 15.27%-3.77M | -71.58%-16.98M | -25.06%-3.95M | -40.51%-4.06M |
| Income tax | ||||||||||
| Net income | 20.78%-3.08M | 4.22%-3.61M | 13.70%-14.65M | 24.22%-3M | 1.43%-4M | 13.98%-3.89M | 15.27%-3.77M | -71.58%-16.98M | -25.06%-3.95M | -40.51%-4.06M |
| Net income continuous Operations | 20.78%-3.08M | 4.22%-3.61M | 13.70%-14.65M | 24.22%-3M | 1.43%-4M | 13.98%-3.89M | 15.27%-3.77M | -71.58%-16.98M | -25.06%-3.95M | -40.51%-4.06M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 20.78%-3.08M | 4.22%-3.61M | 13.70%-14.65M | 24.22%-3M | 1.43%-4M | 13.98%-3.89M | 15.27%-3.77M | -71.58%-16.98M | -25.06%-3.95M | -40.51%-4.06M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 20.78%-3.08M | 4.22%-3.61M | 13.70%-14.65M | 24.22%-3M | 1.43%-4M | 13.98%-3.89M | 15.27%-3.77M | -71.58%-16.98M | -25.06%-3.95M | -40.51%-4.06M |
| Basic earnings per share | 33.33%-0.06 | 0.00%-0.08 | 30.43%-0.32 | 38.68%-0.065 | 22.73%-0.085 | 27.42%-0.09 | 33.33%-0.08 | -31.43%-0.46 | -4.95%-0.106 | -18.28%-0.11 |
| Diluted earnings per share | 33.33%-0.06 | 0.00%-0.08 | 30.43%-0.32 | 38.68%-0.065 | 22.73%-0.085 | 27.42%-0.09 | 33.33%-0.08 | -31.43%-0.46 | -4.95%-0.106 | -18.28%-0.11 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
